Why Sunrun Stock Is Exploding Higher

Sunrun Inc (NASDAQ: RUN) shares are trading higher by 11.8% to $21.11 Thursday morning after the company reported mixed second-quarter results.

Sunrun Inc (NASDAQ:RUN) shares are trading higher by 11.8% to $21.11 Thursday morning after the company reported mixed second-quarter results. Sunrun reported an EPS of 25 cents, surpassing the analyst consensus estimate of a loss of 34 cents. In terms of quarterly sales, Sunrun generated $590.19 million, missing the analyst consensus estimate of $621.86 million by 5.1%.

The company’s sales performance still showed a marginally positive trajectory, with a 1% increase over the $584.58 million recorded during the same period the previous year.

Key operating metrics indicate strong growth, with 39,755 customer additions in second-quarter 2023 and a 20% increase in customers compared to the same period last year.

Sunrun’s financial outlook remains positive, with expectations of 10% to 15% growth in Solar Energy Capacity Installed for the full year 2023.

Total revenue for second-quarter 2023 was $590.2 million, with customer agreements and incentives revenue increasing by 16% compared to second-quarter 2022.

According to data from Benzinga Pro, Sunrun has a 52-week high of $39.13 and a 52-week low of $14.55.

Total
0
Shares
Related Posts
Read More

Travere Therapeutics Announces Topline Results From Two-Year Primary Efficacy Endpoint In Pivotal Phase 3 DUPLEX Study Of Sparsentan In Focal Segmental Glomerulosclerosis; The Duplex Study Did Not Achieve The Primary Efficacy Endpoint Over 108 Weeks

The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with sparsentan resulted in a

TVTX